(1R,2S)-1-(3-fluoro-4-((2-phenylquinolin-4-yl)methoxy)benzyl)-N2-hydroxy-N1,N1-dimethylcyclopropane-1,2-dicarboxamide

ID: ALA496309

PubChem CID: 44580801

Max Phase: Preclinical

Molecular Formula: C30H28FN3O4

Molecular Weight: 513.57

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)[C@@]1(Cc2ccc(OCc3cc(-c4ccccc4)nc4ccccc34)c(F)c2)C[C@@H]1C(=O)NO

Standard InChI:  InChI=1S/C30H28FN3O4/c1-34(2)29(36)30(17-23(30)28(35)33-37)16-19-12-13-27(24(31)14-19)38-18-21-15-26(20-8-4-3-5-9-20)32-25-11-7-6-10-22(21)25/h3-15,23,37H,16-18H2,1-2H3,(H,33,35)/t23-,30+/m1/s1

Standard InChI Key:  QCSQWZYXJSYMSJ-DJUQAAIZSA-N

Molfile:  

     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   10.8480    2.0937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6738    2.0937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2609    2.8106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2399    1.4977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3804    2.5207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1035    2.1249    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3638    3.3487    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2418    0.6729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5243    0.2631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5249   -0.5619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2410   -0.9749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9581   -0.5568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9541    0.2669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0472    1.8810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4646    2.4662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8317    1.0838    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6665    2.2542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2430   -1.8007    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5288   -2.2153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5308   -3.0411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5338   -4.6916    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2504   -4.2726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2452   -3.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8171   -4.2796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8189   -3.4578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1091   -3.0471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3970   -3.4571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3992   -4.2822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1096   -4.6891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1222    1.2994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8091    2.5540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9653   -4.6795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9689   -5.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6856   -5.9150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3993   -5.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3918   -4.6678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6744   -4.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6752   -0.9664    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  8  9  2  0
 18 19  1  0
  1  3  1  0
 19 20  1  0
 20 25  2  0
  9 10  1  0
 24 21  2  0
  2  5  1  0
 21 22  1  0
 10 11  2  0
 22 23  2  0
 23 20  1  0
 11 12  1  0
 24 25  1  0
  2  1  1  0
 25 26  1  0
 12 13  2  0
 26 27  2  0
 13  8  1  0
 27 28  1  0
  5  6  1  0
 28 29  2  0
 29 24  1  0
  1 14  1  1
  6 30  1  0
  5  7  2  0
  6 31  1  0
 14 15  1  0
  3  2  1  0
 32 33  2  0
 14 16  2  0
 33 34  1  0
  4  8  1  0
 34 35  2  0
 15 17  1  0
 35 36  1  0
  2  4  1  1
 36 37  2  0
 37 32  1  0
 22 32  1  0
 11 18  1  0
 12 38  1  0
M  END

Associated Targets(Human)

ADAM10 Tchem ADAM10 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP14 Tchem Matrix metalloproteinase 14 (1592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP7 Tchem Matrix metalloproteinase 7 (1073 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 513.57Molecular Weight (Monoisotopic): 513.2064AlogP: 4.76#Rotatable Bonds: 8
Polar Surface Area: 91.76Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.86CX Basic pKa: 3.66CX LogP: 4.64CX LogD: 4.63
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -0.76

References

1. Mazzola RD, Zhu Z, Sinning L, McKittrick B, Lavey B, Spitler J, Kozlowski J, Neng-Yang S, Zhou G, Guo Z, Orth P, Madison V, Sun J, Lundell D, Niu X..  (2008)  Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.,  18  (21): [PMID:18835710] [10.1016/j.bmcl.2008.09.045]

Source